Wisdom From Top Execs:
David Epstein, Division Head and CEO, Novartis Pharmaceuticals at Novartis AG
Marc Princen, Takeda President, Europe and Canada
Paul Perreault, CEO and Managing Director, CSL Behring
Many CEOs are aware of the need to be more patient-focused, and how to achieve that throughout their organizations. But do they follow through? To underline the advice from our roundtable panel on patient centricity, we offer here testimony from top people in the industry. These are executives who actually walk the walk, making it part of the company DNA. It’s not just an assignment for one executive or group: it has to be a central motivating influence on everyone in the organization. Leaders from Novartis, Takeda and CSL Behring recently shared their visions of how this happens with eyeforpharma.
DAVID EPSTEIN is Division Head and CEO of Novartis Pharmaceuticals at Novartis AG. He has more than 20 years of industry experience, having served as Divisional Head of Global Pharmaceuticals Division at Novartis AG and Novartis Vaccines and Diagnostics, Inc., head of Novartis Oncology at Novartis Institutes for Biomedical Research, Inc., and head of Molecular Diagnostics. Previously he was CEO of Novartis Specialty Medicines, oversaw the global Ophthalmics and Transplantation and Immunology Business Units, and was Head of Specialty Medicines and Oncology at Novartis AG of Novartis India Ltd. Here are excerpts of his talk at eyeforpharma Barcelona on March 15, 2016.
MARC PRINCEN has been Takeda President for Europe and Canada since 2014. He previously held numerous titles at Merck (President Mid Europe, President Diversified Brands), Schering Plough (Regional Vice President Central, Eastern Europe and Middle East, Africa) and Essex Pharma GmbH (Vice President and General Manager). Here, interviewed by Paul Simms of eyeforpharma, he explains that putting the patient at the center “is the issue that drives our company forward.”
PAUL PERREAULT is CEO and Managing Director of CSL Behring. Previously having served as its president, he was responsible for overseeing operations in more than 25 countries, including major manufacturing sites in the United States, Switzerland, Germany and Australia, and an extensive network of plasma collection centers throughout North America and Germany. Prior to this, he was Executive Vice President, Worldwide Commercial Operations with responsibility for all commercial and business development activities globally for CSL Behring.
Mr. Perreault has also held several executive positions at Aventis Behring, including Vice President and General Manager of Plasma Operations at Aventis Bio-Services, and Vice President and General Manager for Aventis Behring Hospital Products in North America and Puerto Rico. Click on the image for audio of his keynote address at eyeforpharma Philadelphia on May 2, 2016.
Paul Simms Chairman, eyeforpharma Paul was General Manager of eyeforpharma from 2003 before moving into his current Chairman role in 2009. Paul has a special interest in new projects, innovation, media and overseeing the general development and direction of the company.
Ulrich Neumann, FRSA, MSc, MA Managing Director of eyeforpharma in North America Ulrich joined eyeforpharma in 2013 to establish the organization’s clinical trials network and presently leads U.S. operations and strategy. His personal research focus is currently on defining patient engagement models from clinical to commercial. Prior to that, he held the Roger Silverstone Fellowship at the University of Southern California, where he also led a pro-bono consulting group supporting clinical trial accrual for underserved communities in Los Angeles. firstname.lastname@example.org eyeforpharma is a global provider of pharmaceutical business insights and networking. Its mission is to make pharma more open and valued. It is creating a movement for industry leaders who prioritize value for patients and healthcare.
CLICK HERE FOR YOUR CAREER
Healthcare Sales & Marketing was created specifically to help people like you learn and grow in the life sciences. Our articles are written by professionals for professionals, and we get great feedback on the benefits they derive from HS&M. Click the subscription button to sign up for a free subscription, so you don’t miss any of the insightful, expert articles we provide all year long.